BALCHEM CORP (BCPC)
Clinical trial NCT06214897 updates: 1. completion date: 2026-06-01 → 2026-12-01 2. primary completion date: 2026-06-01 → 2026-06-22 3. enrollment: 1500 → 1515 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06214897 updates: 1. completion date: 2026-06-01 → 2026-12-01 2. primary completion date: 2026-06-01 → 2026-06-22 3. enrollment: 1500 → 1515 participants 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (61%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (25%) **Content type:** Clinical